| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1
Department of Pathology and Kaplan Cancer Center, New York University School of Medicine, New York, NY 10016
Lymphocytes derived from mice deficient in STAT1 showed reduced
apoptosis and enhanced proliferation in vitro. To understand the
involvement of STAT1 in the observed reduction in apoptosis, we
examined the levels of caspase and bcl-2 family genes that are involved
in cell survival and/or apoptosis. The levels of caspase 1 and 11, two
enzymes involved in both cytokine protein processing and induction of
apoptosis, were reduced in STAT1-/- cells compared with
wild-type. However, the levels of bcl-2 genes were comparable in both
mice. STAT1-/- cells also displayed an enhanced
proliferation following TCR stimulation. This hyperproliferation could
not be ascribed completely to the loss of IFN-
-mediated
antiproliferation. First, similar phenotypes were also observed in
fibroblasts and pre-B cells derived from STAT1-/- mice,
which do not produce IFN-. Second, comparisons with cells lacking
the gene for IFN- or with cells treated with neutralizing Abs to
IFN- only partially mimicked the STAT1-/- phenotype.
Interestingly, the kinetics of degradation of p27kip1, a
CDK inhibitor, following TCR ligation were faster, and, concomitantly,
the up-regulation of CDK2 kinase activity and protein levels were
increased in stimulated T cells of STAT1-/- mice relative
to those of wild-type mice. Furthermore, STAT1-/- animals
were more susceptible to carcinogen-induced thymic tumors, a possible
consequence of altered T cell growth and/or survival. These results
demonstrate an essential role for STAT1 for lymphocyte survival and
proliferation that is only partially dependent on IFN-
signaling.
This article has been cited by other articles:
|
|
 |
|
  A. Pilz, W. Kratky, S. Stockinger, O. Simma, U. Kalinke, K. Lingnau, A. von Gabain, D. Stoiber, V. Sexl, T. Kolbe, et al. Dendritic Cells Require STAT-1 Phosphorylated at Its Transactivating Domain for the Induction of Peptide-Specific CTL J. Immunol., August 15, 2009; 183(4): 2286 - 2293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Najjar, P. O. Schischmanoff, F. Baran-Marszak, P.-A. Deglesne, I. Youlyouz-Marfak, M. Pampin, J. Feuillard, G. W. Bornkamm, M. K. Chelbi-Alix, and R. Fagard Novel function of STAT1{beta} in B cells: induction of cell death by a mechanism different from that of STAT1{alpha} J. Leukoc. Biol., December 1, 2008; 84(6): 1604 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hosui and L. Hennighausen Genomic dissection of the cytokine-controlled STAT5 signaling network in liver Physiol Genomics, July 1, 2008; 34(2): 135 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. de Totero, R. Meazza, M. Capaia, M. Fabbi, B. Azzarone, E. Balleari, M. Gobbi, G. Cutrona, M. Ferrarini, and S. Ferrini The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways Blood, January 15, 2008; 111(2): 517 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. N. Khodarev, A. J. Minn, E. V. Efimova, T. E. Darga, E. Labay, M. Beckett, H. J. Mauceri, B. Roizman, and R. R. Weichselbaum Signal Transducer and Activator of Transcription 1 Regulates Both Cytotoxic and Prosurvival Functions in Tumor Cells Cancer Res., October 1, 2007; 67(19): 9214 - 9220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Stout, K. Melendez, J. Seagrave, M. J. Holtzman, B. Wilson, J. Xiang, and Y. Tesfaigzi STAT1 Activation Causes Translocation of Bax to the Endoplasmic Reticulum during the Resolution of Airway Mucous Cell Hyperplasia by IFN-{gamma} J. Immunol., June 15, 2007; 178(12): 8107 - 8116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Cuesta, Q. M. Nhu, E. Zudaire, S. Polumuri, F. Cuttitta, and S. N. Vogel IFN Regulatory Factor-2 Regulates Macrophage Apoptosis through a STAT1/3- and Caspase-1-Dependent Mechanism J. Immunol., March 15, 2007; 178(6): 3602 - 3611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Konforte and C. J. Paige Identification of Cellular Intermediates and Molecular Pathways Induced by IL-21 in Human B Cells J. Immunol., December 15, 2006; 177(12): 8381 - 8392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-C. Chou, D. E. Levy, and C.-K. Lee STAT3 positively regulates an early step in B-cell development Blood, November 1, 2006; 108(9): 3005 - 3011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Garcia-Sastre and C. A. Biron Type 1 interferons and the virus-host relationship: a lesson in detente . Science, May 12, 2006; 312(5775): 879 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. de Totero, R. Meazza, S. Zupo, G. Cutrona, S. Matis, M. Colombo, E. Balleari, I. Pierri, M. Fabbi, M. Capaia, et al. Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells Blood, May 1, 2006; 107(9): 3708 - 3715. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Gysemans, L. Ladriere, H. Callewaert, J. Rasschaert, D. Flamez, D. E. Levy, P. Matthys, D. L. Eizirik, and C. Mathieu Disruption of the {gamma}-Interferon Signaling Pathway at the Level of Signal Transducer and Activator of Transcription-1 Prevents Immune Destruction of {beta}-cells Diabetes, August 1, 2005; 54(8): 2396 - 2403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gimeno, C.-K. Lee, C. Schindler, and D. E. Levy Stat1 and Stat2 but Not Stat3 Arbitrate Contradictory Growth Signals Elicited by Alpha/Beta Interferon in T Lymphocytes Mol. Cell. Biol., July 1, 2005; 25(13): 5456 - 5465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Takeda, S. Hamano, H. Shiraishi, T. Yoshimura, H. Ogata, K. Ishii, T. Ishibashi, A. Yoshimura, and H. Yoshida WSX-1 over-expression in CD4+ T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation Int. Immunol., July 1, 2005; 17(7): 889 - 897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Huang, Y.-Y. Zhang, K. Chen, K. Hatakeyama, and J. F. Keaney Jr Cytokine-Stimulated GTP Cyclohydrolase I Expression in Endothelial Cells Requires Coordinated Activation of Nuclear Factor-{kappa}B and Stat1/Stat3 Circ. Res., February 4, 2005; 96(2): 164 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tanabe, T. Nishibori, L. Su, R. M. Arduini, D. P. Baker, and M. David Cutting Edge: Role of STAT1, STAT3, and STAT5 in IFN-{alpha}{beta} Responses in T Lymphocytes J. Immunol., January 15, 2005; 174(2): 609 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Halupa, M. L. Bailey, K. Huang, N. N. Iscove, D. E. Levy, and D. L. Barber A novel role for STAT1 in regulating murine erythropoiesis: deletion of STAT1 results in overall reduction of erythroid progenitors and alters their distribution Blood, January 15, 2005; 105(2): 552 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Villarino, E. Huang, and C. A. Hunter Understanding the Pro- and Anti-Inflammatory Properties of IL-27 J. Immunol., July 15, 2004; 173(2): 715 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Townsend, T. M. Scarabelli, S. M. Davidson, R. A. Knight, D. S. Latchman, and A. Stephanou STAT-1 Interacts with p53 to Enhance DNA Damage-induced Apoptosis J. Biol. Chem., February 13, 2004; 279(7): 5811 - 5820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Sironi and T. Ouchi STAT1-induced Apoptosis Is Mediated by Caspases 2, 3, and 7 J. Biol. Chem., February 6, 2004; 279(6): 4066 - 4074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Schroder, P. J. Hertzog, T. Ravasi, and D. A. Hume Interferon-{gamma}: an overview of signals, mechanisms and functions J. Leukoc. Biol., February 1, 2004; 75(2): 163 - 189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. W. Sternberg and D. G. Gilliland The Role of Signal Transducer and Activator of Transcription Factors in Leukemogenesis J. Clin. Oncol., January 15, 2004; 22(2): 361 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nishibori, Y. Tanabe, L. Su, and M. David Impaired Development of CD4+ CD25+ Regulatory T Cells in the Absence of STAT1: Increased Susceptibility to Autoimmune Disease J. Exp. Med., January 5, 2004; 199(1): 25 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Lieberman, M. Banica, S. L. Reiner, and C. A. Hunter STAT1 Plays a Critical Role in the Regulation of Antimicrobial Effector Mechanisms, but Not in the Development of Th1-Type Responses during Toxoplasmosis J. Immunol., January 1, 2004; 172(1): 457 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. E. Battle, W. G. Wierda, L. Z. Rassenti, D. Zahrieh, D. Neuberg, T. J. Kipps, and D. A. Frank In Vivo Activation of Signal Transducer and Activator of Transcription 1 after CD154 Gene Therapy for Chronic Lymphocytic Leukemia Is Associated with Clinical and Immunologic Response Clin. Cancer Res., June 1, 2003; 9(6): 2166 - 2172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Dondi, L. Rogge, G. Lutfalla, G. Uze, and S. Pellegrini Down-Modulation of Responses to Type I IFN Upon T Cell Activation J. Immunol., January 15, 2003; 170(2): 749 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schauvliege, J. Vanrobaeys, P. Schotte, and R. Beyaert Caspase-11 Gene Expression in Response to Lipopolysaccharide and Interferon-gamma Requires Nuclear Factor-kappa B and Signal Transducer and Activator of Transcription (STAT) 1 J. Biol. Chem., October 25, 2002; 277(44): 41624 - 41630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Widschwendter, S. Tonko-Geymayer, T. Welte, G. Daxenbichler, C. Marth, and W. Doppler Prognostic Significance of Signal Transducer and Activator of Transcription 1 Activation in Breast Cancer Clin. Cancer Res., October 1, 2002; 8(10): 3065 - 3074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Agrawal, M. L. Agarwal, M. Chatterjee-Kishore, G. R. Stark, and G. M. Chisolm Stat1-Dependent, p53-Independent Expression of p21waf1 Modulates Oxysterol-Induced Apoptosis Mol. Cell. Biol., April 1, 2002; 22(7): 1981 - 1992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Levy Whence Interferon? Variety in the Production of Interferon in Response to Viral Infection J. Exp. Med., February 19, 2002; 195(4): F15 - F18. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Maier, C. Kincaid, A. Pagenstecher, and I. L. Campbell Regulation of Signal Transducer and Activator of Transcription and Suppressor of Cytokine-Signaling Gene Expression in the Brain of Mice with Astrocyte-Targeted Production of Interleukin-12 or Experimental Autoimmune Encephalomyelitis Am. J. Pathol., January 1, 2002; 160(1): 271 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bernabei, E. M. Coccia, L. Rigamonti, M. Bosticardo, G. Forni, S. Pestka, C. D. Krause, A. Battistini, and F. Novelli Interferon-{gamma} receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death J. Leukoc. Biol., December 1, 2001; 70(6): 950 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yoshikawa, Y. Nakajima, and K. Tasaka IFN-{gamma} Induces the Apoptosis of WEHI 279 and Normal Pre-B Cell Lines by Expressing Direct Inhibitor of Apoptosis Protein Binding Protein with Low pI J. Immunol., September 1, 2001; 167(5): 2487 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. V. Ramana, M. P. Gil, Y. Han, R. M. Ransohoff, R. D. Schreiber, and G. R. Stark Stat1-independent regulation of gene expression in response to IFN-gamma PNAS, June 5, 2001; 98(12): 6674 - 6679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sahni, R. Raz, J. D. Coffin, D. Levy, and C. Basilico STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2 Development, June 1, 2001; 128(11): 2119 - 2129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-K. Lee, D. T. Rao, R. Gertner, R. Gimeno, A. B. Frey, and D. E. Levy Distinct Requirements for IFNs and STAT1 in NK Cell Function J. Immunol., October 1, 2000; 165(7): 3571 - 3577. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
